Found 6 matching trials
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
PHASE2Study Objective: To determine the efficacy of upfront immune checkpoint inh...
Location
Multiple Locations
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial
NABACKGROUND: The role of cytoreductive nephrectomy (CN) in the treatment of ...
Location
Gangnam Severance Hospital
Deferred Cytoreductive Nephrectomy in Synchronous Metastatic Renal Cell Carcinoma: The NORDIC-SUN-Trial
NABACKGROUND: For synchronous metastatic renal cell carcinoma (RCC), surgical...
Location
Department of Oncology, Aarhus University Hospital
Immediate Versus Deferred Cytoreductive Nephrectomy With Ipilimumab/Nivolumab in mRCC
NAThe goal of this clinical trial is to learn whether the timing of surgery (...
Location
Multiple Locations
TACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell Carcinoma
PHASE2This prospective, open-label, single-arm Phase 2 study is evaluating toripa...
Location
Multiple Locations
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
PHASE4This is Phase IV, randomized, multi arm, multicenter, low interventional cl...
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS